Trillium Therapeutics Inc (TRIL)

[fink]

There is your buy out partner. Figures.

I will assume a deal is already made once Trillium gains an FDA approval.,
This is a repeat of (MITI) Micromet.

In September 2020, the Company issued 2,297,794 common shares at a price of $10.88 per share to Pfizer Inc. in a registered direct offering. The gross proceeds from this offering were $25.0 million, before deducting offering expenses of $0.1 million.